全文获取类型
收费全文 | 4290篇 |
免费 | 223篇 |
国内免费 | 45篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 97篇 |
妇产科学 | 58篇 |
基础医学 | 557篇 |
口腔科学 | 86篇 |
临床医学 | 211篇 |
内科学 | 997篇 |
皮肤病学 | 52篇 |
神经病学 | 429篇 |
特种医学 | 107篇 |
外科学 | 885篇 |
综合类 | 25篇 |
预防医学 | 52篇 |
眼科学 | 42篇 |
药学 | 340篇 |
中国医学 | 21篇 |
肿瘤学 | 577篇 |
出版年
2023年 | 27篇 |
2022年 | 41篇 |
2021年 | 65篇 |
2020年 | 46篇 |
2019年 | 79篇 |
2018年 | 81篇 |
2017年 | 80篇 |
2016年 | 84篇 |
2015年 | 105篇 |
2014年 | 117篇 |
2013年 | 146篇 |
2012年 | 256篇 |
2011年 | 289篇 |
2010年 | 177篇 |
2009年 | 124篇 |
2008年 | 234篇 |
2007年 | 235篇 |
2006年 | 251篇 |
2005年 | 249篇 |
2004年 | 233篇 |
2003年 | 198篇 |
2002年 | 232篇 |
2001年 | 125篇 |
2000年 | 116篇 |
1999年 | 130篇 |
1998年 | 64篇 |
1997年 | 49篇 |
1996年 | 50篇 |
1995年 | 33篇 |
1994年 | 37篇 |
1993年 | 35篇 |
1992年 | 62篇 |
1991年 | 58篇 |
1990年 | 46篇 |
1989年 | 50篇 |
1988年 | 37篇 |
1987年 | 38篇 |
1986年 | 53篇 |
1985年 | 41篇 |
1984年 | 27篇 |
1983年 | 26篇 |
1982年 | 10篇 |
1981年 | 10篇 |
1980年 | 9篇 |
1978年 | 9篇 |
1977年 | 10篇 |
1976年 | 8篇 |
1975年 | 13篇 |
1973年 | 11篇 |
1966年 | 8篇 |
排序方式: 共有4558条查询结果,搜索用时 15 毫秒
1.
2.
Peroxisome proliferator-activated receptor delta (PPARdelta), a novel target site for drug discovery in metabolic syndrome. 总被引:5,自引:0,他引:5
Sadao Takahashi Toshiya Tanaka Tatsuhiko Kodama Juro Sakai 《Pharmacological research》2006,53(6):501-507
The development of new treatments for metabolic syndrome is urgent project for decreasing the prevalence of coronary heart disease and diabetes mellitus in the advanced countries. Peroxisome proliferator-activated receptor (PPAR)alpha and gamma agonists have shed light on the treatment of hypertriglyceridemia and type 2 diabetes mellitus, respectively. Among PPARs, analysis of the PPARdelta functions is lagging behind because specific PPARdelta agonists have not been developed. The appearance of new PPARdelta agonists is brightening the prospects for elucidating the physiological role of PPARdelta. PPARdelta is a new target for the treatment of metabolic syndrome. In particular, the fact that fatty acid oxidation and energy dissipation in skeletal muscle and adipose tissue by PPARdelta agonists lead to improved lipid profile, reduced adiposity and insulin sensitivity is a breakthrough. It seems that treatment of PPARdelta agonists operate similarly to the caloric restriction and prolonged exercise. We suggest that the physiological role of PPARdelta may be an indicator for switching from glucose metabolism to fatty acid metabolism. To receive new benefits of PPARdelta agonists against metabolic syndrome by increasing fatty acid consumption in skeletal muscle and adipose tissue, we need to unveil more details on the functions of PPARdelta itself and its agonists in the future. 相似文献
3.
K Suzuki K Takanashi Y Naide T Fujita T Ogawa S Hirabayashi H Tamai M Yanaoka K Ishiguro H Asano 《Hinyokika kiyo. Acta urologica Japonica》1986,32(9):1387-1408
MK-0787 (Imipenem)/MK-0791 (Cilastatin sodium), a new compound of Thienamycin, was administered in treatment of 35 patients (36 cases) with chronic complicated UTI or for prevention of serious infections with much complicated factors. The patients were principally treated at a daily dose of 1 g for over 10 days. The efficacy rate of 26 patients who were evaluable in the early phase (4-7 days) was 88.5%, while it became up to 92.3% in the final phase judgment. As for clinical usefulness, the result was obtained to be as high as that of the clinical efficacy. In bacteriological study, 35 strains were clinically isolated including 7 strains of P. aeruginosa from UTI. All the strains disappeared with an eradication rate of 100% after treatment. Strains appearing after Imipenem/Cilastatin sodium treatment mainly consisted of fungi. Usefulness judgements tended to be greater in the final phase than in the early phase. As for side effects, vomiting was recorded in one case, in which the administration was discontinued. In laboratory findings there were 3 cases with elevated GPT, 2 cases with elevated GOT, one case with elevated gamma-GTP, one with thrombocytopenia, and one with eosinophilia each, but these abnormal values were slight and transient. In summary our clinical study showed that Imipenem/Cilastatin sodium was a very effective antibiotic in treatment on moderate or serious UTI or preventive use for infections in compromised hosts. Considering the features of this agent, it might be more effective and useful for clinical use in treatment on polymicrobial infections including stubborn organisms than any other antimicrobial compounds. Furthermore, it was safe and well tolerable in a long term treatment. 相似文献
4.
5.
S Miyajima Y Aizawa K Suzuki M Satoh S Niwano K Ebe T Fujita J Ishiguro Y Hirokawa A Shibata 《Japanese heart journal》1989,30(2):241-249
Recently, we examined 2 cases of hypertrophic cardiomyopathy (HCM) presenting with sustained ventricular tachycardia (VT). One case was a 62 year old male with midventricular hypertrophy and monomorphic sustained VT. After admission, the efficacies of procainamide, disopyramide, aprindin, flecainide, mexiletine and verapamil were evaluated by means of continuous electrocardiographic monitoring. Verapamil prevented the recurrence of sustained VT and markedly reduced the frequency and number of runs of nonsustained VT. In the electrophysiologic study, rapid VT was induced by double extrastimuli at the right ventricular apex. Intravenous verapamil at a dose of 10 mg prevented the induction of VT. The patient was discharged on verapamil and remains asymptomatic after 3 months of follow up. The other case was a 34 year old female who was a survivor of cardiac arrest. Monomorphic VT was observed on emergency admission and was converted to sinus rhythm by direct current cardioversion after resuscitation. In the electrophysiologic study, rapid VT was induced by double extrastimuli at the right ventricular outflow tract. Verapamil at a dose of 10 mg prevented the induction of VT. These 2 cases of HCM are rare in that they presented with sustained VT. It is also of interest that verapamil, which has been used conventionally in HCM, prevented VT. 相似文献
6.
7.
Toshiya Takemura Masazumi Watanabe Keigo Takagi Susumu Tanaka Shinsuke Aida 《Surgery today》1995,25(7):651-653
We present herein the rare case of a young man who was found to have a solitary tumor in the right upper lobe of his lung by a routine chest X-ray. The tumor was removed by thoracoscopic surgery, and pathological examinations confirmed the diagnosis of a primary lymphangioma of the lung. A brief review of the available literature on this extremely rare type of benign tumor follows the case report. 相似文献
8.
R Shiroki M Izumitani Y Tsukiashi S Saito K Ishiguro Y Fujioka I Nagakubo 《Hinyokika kiyo. Acta urologica Japonica》1990,36(11):1385-1388
Vasopressin, a hormone secreted from the posterior lobe of the hypophysis, has endocrinological and antidiuretic effects; it contracts vessels and smooth muscles, especially intestinal smooth muscle. In the present study, we investigated the role of vasopressin (Pitressin: arginine-vasopressin) in elimination of intestinal gas on excretory urography reading. Sixty outpatients were randomly divided into six groups. In Group I, the routine procedure was employed, i.e. laxatives the previous night and NPO the morning of the examination. In Groups II to VI, different dose regimens were employed: 6 or 10 units of Pitressin was administered by subcutaneous injection 30 minutes prior to injection of a contrast medium, with or without NPO. Intestinal gas elimination was evaluated by X-ray films taken before and after injection of Pitressin. The efficacy was rated by four grades. There were no significant differences in the gas elimination or occurrence of side effects between any two groups. Younger patients seemed to respond quickly to Pitressin and good effects were obtained. These results indicate that the pretreatment for excretory urography with 6 units of Pitressin without NPO may be a safe and effective alternative method for elimination of intestinal gas, in particular for young patients. 相似文献
9.
S Ishiguro A Kimura S Munemoto K Shoin K Futami H Shimizu 《No shinkei geka. Neurological surgery》1986,14(13):1595-1599
A 47-year-old male was concerned with a large AVM involved extensively in the parietal region and the posterior fossa. Radiological examinations showed multiple radiolucencies in the parietal and occipital bone and torturous vascular nets (nidus) in those bones on the angiograms. Nidus was found also in the dura mater in the posterior fossa. Therefore, this case seemed to be an extremely rare case of calvarial AVM in the parietal region with the mixed calvarial dural AVM in the posterior fossa. His symptoms were bruit, transient hemiparesis and Gerstmann's syndrome in addition to the symptoms due to raised intracranial pressure. Favorable results of therapies could be attained by extensive exfoliation of dura mater from the cranial bone and incision of proximal dura mater in the sinus. 相似文献
10.
Kaname Ishii Yuichi Hayashida Katsuhiro Yoshimoto Hidehiro Tajima Uichiro Fuchisaki Toshiya Takeda Toru Kamata Hirotoshi Miyamori Masahiro Kanno 《Nihon Shokakibyo Gakkai zasshi》2006,103(8):931-935
We report a case of granulocyte-colony stimulating factor producing gastric cancer with multiple liver metastases. A 68-year-old woman who complained of epigastralgia visited our hospital. Upper gastrointestinal endoscopic examination revealed a type-2 gastric cancer. The laboratory data at admission indicated leukocytosis (35,900/microl) and a high level of serum granulocyte-colony stimulating factor (61 pg/mg). Granulocyte-colony stimulating factor producing gastric cancer was diagnosed by immunohistochemistry of biopsy specimen. Since we detected multiple liver metastases, chemotherapy was performed. Granulocyte-colony stimulating factor-producing gastric cancer is relatively rare and we summarize previous reports. 相似文献